Proteomic profiling of Burkholderia cenocepacia clonal isolates with different virulence potential retrieved from a cystic fibrosis patient during chronic lung infection

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Madeira, Andreia ^a   Dos Santos, Sandra C ^a   Santos, Pedro M ^a,c   Coutinho, Carla P ^a   Tyrrell, Jean ^b   McClean, Siobhán ^b   Callaghan, Máire ^b   Sá Correia, Isabel ^a  

^a Instituto de Biotecnologia e Bioengenharia Lisboa   (Portugal)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^c UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; SIDEROPHORE; BACTERIAL PROTEIN; VIRULENCE FACTOR;

ARTICLE; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BURKHOLDERIA CENOCEPACIA; CELL INVASION; CELL MEMBRANE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOPLASM; EPITHELIUM CELL; HUMAN; HUMAN CELL; IRON TRANSPORT; LUNG ALVEOLUS EPITHELIUM; LUNG INFECTION; NONHUMAN; PROTEOMICS; BACTERIAL PNEUMONIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTION; CLINICAL TRIAL; FEMALE; GENETICS; MALE; METABOLISM; PATHOGENICITY;

BACTERIAL PROTEINS; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; FEMALE; HUMANS; MALE; PNEUMONIA, BACTERIAL; PROTEOMICS; VIRULENCE FACTORS;

EID: 84892668082     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083065     Document Type: Article

References (56)

1. Drevinek P, Mahenthiralingam E (2010) Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect 16: 821-830. doi:10.1111/j.1469-0691.2010.03237.x. PubMed: 20880411.
2. Mahenthiralingam E, Baldwin A, Vandamme P (2002) Burkholderia cepacia complex infection in patients with cystic fibrosis. J Med Microbiol 51: 533-538. PubMed: 12132768.
3. Burns JL (2007) Antibiotic resistance of Burkholderia spp. In: T CoenyeP Vandamme. Bukholderia: Molecular Microbiology and Genomics. Norfolk: Horizon Scientific Press.
4. Mahenthiralingam E, Urban TA, Goldberg JB (2005) The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 3: 144-156. doi:10.1038/nrmicro1085. PubMed: 15643431.
5. Döring G, Parameswaran IG, Murphy TF (2011) Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease. FEMS Microbiol Rev 35: 124-146. doi:10.1111/j.1574-6976.2010.00237.x. PubMed: 20584083.
6. Harrison F (2007) Microbial ecology of the cystic fibrosis lung. Microbiology (Reading, Engl) 153: 917-923.
7. Coutinho CP, dos Santos SC, Madeira A, Mira NP, Moreira AS et al. (2011) Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations. Front Cell Inf Microbio 1: 1-11.
8. Coutinho CP, de Carvalho CC, Madeira A, Pinto-de-Oliveira A, Sá-Correia I (2011) Burkholderia cenocepacia phenotypic clonal variation during a 3.5-year colonization in the lungs of a cystic fibrosis patient. Infect Immun 79: 2950-2960. doi:10.1128/IAI.01366-10. PubMed: 21536796.
9. Lieberman TD, Michel JB, Aingaran M, Potter-Bynoe G, Roux D et al. (2011) Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet 43: 1275-1280. doi:10.1038/ng.997. PubMed: 22081229.
10. Cunha MV, Sousa SA, Leitão JH, Moreira LM, Videira PA et al. (2004) Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J Clin Microbiol 42: 3052-3058. doi:10.1128/JCM.42.7.3052-3058.2004. PubMed: 15243059.
11. Loutet SA, Valvano MA (2010) A decade of Burkholderia cenocepacia virulence determinant research. Infect Immun 78: 4088-4100. doi:10.1128/IAI. 00212-10. PubMed: 20643851.
12. Mira NP, Madeira A, Moreira AS, Coutinho CP, Sá-Correia I (2011) Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients' airways and antimicrobial therapy. PLOS ONE 6: e28831. doi:10.1371/journal.pone.0028831. PubMed: 22216120.
13. Madeira A, Santos PM, Coutinho CP, Pinto-de-Oliveira A, Sá-Correia I (2011) Quantitative proteomics (2-D DIGE) reveals molecular strategies employed by Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under antimicrobial therapy. Proteomics 11: 1313-1328. doi:10.1002/pmic.201000457. PubMed: 21337515.
14. Cunha MV, Leitão JH, Mahenthiralingam E, Vandamme P, Lito L et al. (2003) Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. J Clin Microbiol 41: 4113-4120. doi:10.1128/JCM.41.9.4113-4120.2003. PubMed: 12958234.
15. Richau JA, Leitão JH, Correia M, Lito L, Salgado MJ et al. (2000) Molecular typing and exopolysaccharide biosynthesis of Burkholderia cepacia isolates from a Portuguese cystic fibrosis center. J Clin Microbiol 38: 1651-1655. PubMed: 10747161.
16. Mariappan V, Vellasamy KM, Thimma JS, Hashim OH, Vadivelu J (2010) Identification of immunogenic proteins from Burkholderia cepacia secretome using proteomic analysis. Vaccine 28: 1318-1324. doi:10.1016/j.vaccine.2009.11.027. PubMed: 19944788.
17. Wongtrakoongate P, Mongkoldhumrongkul N, Chaijan S, Kamchonwongpaisan S, Tungpradabkul S (2007) Comparative proteomic profiles and the potential markers between Burkholderia pseudomallei and Burkholderia thailandensis. Mol Cell Probes 21: 81-91. doi:10.1016/j.mcp.2006.08.006. PubMed: 17030112.
18. Traverse CC, Mayo-Smith LM, Poltak SR, Cooper VS (2013) Tangled bank of experimentally evolved Burkholderia biofilms reflects selection during chronic infections. Proc Natl Acad Sci U S A 110: E250-E259. doi:10.1073/pnas. 1207025110. PubMed: 23271804.
19. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L et al. (1994) CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 10: 38-47. doi:10.1165/ajrcmb.10.1. 7507342. PubMed: 7507342.
20. Ehrhardt C, Collnot EM, Baldes C, Becker U, Laue M et al. (2006) Towards an in vitro model of cystic fibrosis small airway epithelium: characterisation of the human bronchial epithelial cell line CFBE41o. Cell Tissue Res 323: 405-415. doi:10.1007/s00441-005-0062-7. PubMed: 16249874.
21. Zeitlin PL, Lu L, Rhim J, Cutting G, Stetten G et al. (1991) A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am J Respir Cell Mol Biol 4: 313-319. doi:10.1165/ajrcmb/4.4.313. PubMed: 1849726.
22. Winsor GL, Khaira B, Van Rossum T, Lo R, Whiteside MD et al. (2008) The Burkholderia Genome Database: facilitating flexible queries and comparative analyses. Bioinformatics 24: 2803-2804. doi:10.1093/bioinformatics/btn524. PubMed: 18842600.
23. Schwyn B, Neilands JB (1987) Universal chemical assay for the detection and determination of siderophores. Anal Biochem 160: 47-56. doi:10.1016/0003- 2697(87)90612-9. PubMed: 2952030.
24. Cunha MV, Leitão JH, Mahenthiralingam E, Vandamme P, Lito L et al. (2003) Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. J Clin Microbiol 41: 4113-4120. doi:10.1128/JCM.41.9.4113-4120.2003. PubMed: 12958234.
25. Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105-132. doi:10.1016/0022-2836(82)90515-0. PubMed: 7108955.
26. Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL et al. (1999) Protein identification and analysis tools in the ExPASy server. Methods Mol Biol 112: 531-552. PubMed: 10027275.
27. Nouwens AS, Cordwell SJ, Larsen MR, Molloy MP, Gillings M et al. (2000) Complementing genomics with proteomics: the membrane subproteome of Pseudomonas aeruginosa PAO1. Electrophoresis 21: 3797-3809. doi:10.1002/1522-2683(200011)21: 17. PubMed: 11271498.
28. Wilkins MR, Gasteiger E, Sanchez JC, Bairoch A, Hochstrasser DF (1998) Two-dimensional gel electrophoresis for proteome projects: the effects of protein hydrophobicity and copy number. Electrophoresis 19: 1501-1505. doi:10.1002/elps.1150190847. PubMed: 9694302.
29. Molloy MP (2000) Two-dimensional electrophoresis of membrane proteins using immobilized pH gradients. Anal Biochem 280: 1-10. doi:10.1006/abio.2000. 4514. PubMed: 10805514.
30. Drevinek P, Holden M, Ge Z, Jones A, Ketchell I et al. (2008) Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infect Dis 8: 121. doi:10.1186/1471-2334-8-121. PubMed: 18801206.
31. Piette J, Nyunoya H, Lusty CJ, Cunin R, Weyens G et al. (1984) DNA sequence of the carA gene and the control region of carAB: tandem promoters, respectively controlled by arginine and the pyrimidines, regulate the synthesis of carbamoyl-phosphate synthetase in Escherichia coli K-12. Proc Natl Acad Sci U S A 81: 4134-4138. doi:10.1073/pnas.81.13.4134. PubMed: 6330744.
32. Köhler S, Ekaza E, Paquet JY, Walravens K, Teyssier J et al. (2002) Induction of dnaK through its native heat shock promoter is necessary for intramacrophagic replication of Brucella suis. Infect Immun 70: 1631-1634. doi:10.1128/IAI.70.3.1631-1634.2002. PubMed: 11854256.
33. Nikaido H (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67: 593-656. doi:10.1128/MMBR.67.4.593-656. 2003. PubMed: 14665678.
34. Malinverni JC, Werner J, Kim S, Sklar JG, Kahne D et al. (2006) YfiO stabilizes the YaeT complex and is essential for outer membrane protein assembly in Escherichia coli. Mol Microbiol 61: 151-164. doi:10.1111/j.1365-2958.2006. 05211.x. PubMed: 16824102.
35. Agnoli K, Lowe CA, Farmer KL, Husnain SI, Thomas MS (2006) The ornibactin biosynthesis and transport genes of Burkholderia cenocepacia are regulated by an extracytoplasmic function s Factor which is a part of the Fur regulon. J Bacteriol 188: 3631-3644. doi:10.1128/JB.188.10.3631-3644.2006. PubMed: 16672617.
36. Bevivino A, Pirone L, Pilkington R, Cifani N, Dalmastri C et al. (2012) Interaction of environmental Burkholderia cenocepacia strains with cystic fibrosis and non-cystic fibrosis bronchial epithelial cells in vitro. Microbiology 158: 1325-1333. doi:10.1099/mic.0.056986-0. PubMed: 22322958.
37. Pier GB, Grout M, Zaidi TS (1997) Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci U S A 94: 12088-12093. doi:10.1073/pnas.94.22.12088. PubMed: 9342367.
38. Cieri MV, Mayer-Hamblett N, Griffith A, Burns JL (2002) Correlation between an in vitro invasion assay and a murine model of Burkholderia cepacia lung infection. Infect Immun 70: 1081-1086. doi:10.1128/IAI.70.3.1081-1086.2002. PubMed: 11854186.
39. Hesterkamp T, Hauser S, Lutcke H, Bukau B (1996) Escherichia coli trigger factor is a prolyl isomerase that associates with nascent polypeptide chains. Proc Natl Acad Sci U S A 93: 4437-4441. doi:10.1073/pnas.93.9.4437. PubMed: 8633085.
40. + remodeling protein and the DnaK chaperone system. Proc Natl Acad Sci U S A 104: 11138-11144. doi:10.1073/pnas.0703980104. PubMed: 17545305.
41. Mayhew M, Silva AC, Martin J, Erdjument-Bromage H, Tempst P et al. (1996) Protein folding in the central cavity of the GroEL-GroES chaperonin complex. Nature 379: 420-426. doi:10.1038/379420a0. PubMed: 8559246.
42. Foti JJ, Devadoss B, Winkler JA, Collins JJ, Walker GC (2012) Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics. Science 336: 315-319. doi:10.1126/science.1219192. PubMed: 22517853.
43. Schwager S, Agnoli K, Kothe M, Feldmann F, Givskov M et al. (2013) Identification of Burkholderia cenocepacia Strain H111 virulence factors using nonmammalian infection hosts. Infect Immun 81: 143-153. doi:10.1128/IAI.00768- 12. PubMed: 23090963.
44. Samant S, Lee H, Ghassemi M, Chen J, Cook JL et al. (2008) Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLOS Pathog 4: e37. doi:10.1371/journal.ppat.0040037. PubMed: 18282099.
45. Ratledge C, Dover LG (2000) Iron metabolism in pathogenic bacteria. Annu Rev Microbiol 54: 881-941. doi:10.1146/annurev.micro.54.1.881. PubMed: 11018148.
46. Tolman JS, Valvano MA (2012) Global changes in gene expression by the opportunistic pathogen Burkholderia cenocepacia in response to internalization by murine macrophages. BMC Genomics 13: 63. doi:10.1186/1471-2164-13-63. PubMed: 22321740.
47. Oberhardt MA, Goldberg JB, Hogardt M, Papin JA (2010) Metabolic network analysis of Pseudomonas aeruginosa during chronic cystic fibrosis lung infection. J Bacteriol 192: 5534-5548. doi:10.1128/JB.00900-10. PubMed: 20709898.
48. Hoboth C, Hoffmann R, Eichner A, Henke C, Schmoldt S et al. (2009) Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis 200: 118-130. doi:10.1086/599360. PubMed: 19459782.
49. Sass AM, Schmerk C, Agnoli K, Norville PJ, Eberl L, et al. (2013) The unexpected discovery of a novel low-oxygen-activated locus for the anoxic persistence of Burkholderia cenocepacia. Isme J
50. Lieberman TD, Michel JB, Aingaran M, Potter-Bynoe G, Roux D et al. (2011) Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet 43: 1275-1280. doi:10.1038/ng.997. PubMed: 22081229.
51. Huber B, Feldmann F, Kothe M, Vandamme P, Wopperer J et al. (2004) Identification of a novel virulence factor in Burkholderia cenocepacia H111 required for efficient slow killing of Caenorhabditis elegans. Infect Immun 72: 7220-7230. doi:10.1128/IAI. 72.12.7220-7230.2004. PubMed: 15557647.
52. Uehlinger S, Schwager S, Bernier SP, Riedel K, Nguyen DT et al. (2009) Identification of specific and universal virulence factors in Burkholderia cenocepacia strains by using multiple infection hosts. Infect Immun 77: 4102-4110. doi:10.1128/IAI.00398-09. PubMed: 19528212.
53. Vellasamy KM, Mariappan V, Hashim OH, Vadivelu J (2012) Functions of Burkholderia virulence factors: input from proteomics and DNA microarray analyses. Journal Analytical Science and Technology 3: 72-80.
54. Hunt TA, Kooi C, Sokol PA, Valvano MA (2004) Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun 72: 4010-4022. doi:10.1128/IAI.72.7.4010-4022.2004. PubMed: 15213146.
55. Sass A, Marchbank A, Tullis E, Lipuma JJ, Mahenthiralingam E (2011) Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. BMC Genomics 12: 373. doi:10.1186/1471-2164-12-373. PubMed: 21781329.
56. Mariappan V, Vellasamy KM, Hashim OH, Vadivelu J (2011) Profiling of Burkholderia cepacia secretome at mid-logarithmic and early-stationary phases of growth. PLOS ONE 6: e26518. doi:10.1371/journal.pone.0026518. PubMed: 22046299.